On the other hand, the SP-aPL group displayed significantly less arterial thrombosis than the control group (OR = 0.4, 95% CI 0.2–0.8, p = 0.007), with no significant difference between SN-APS and control patients (p = 0.711). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.